Virtual reality and glowing dye could make lung cancer surgery safer
NCT ID NCT06638125
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 30 times
Summary
This study tests a new way to perform lung cancer surgery using 3D virtual reality models and a special dye that makes lung segments glow during surgery. The goal is to help surgeons remove only the diseased part of the lung more accurately. About 89 adults with early-stage non-small cell lung cancer will take part. The study will check if the technique is safe, feasible, and improves surgical success.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, L8N 4A6, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Indocyanine green (ICG) dye
What this could lead to
If successful, this could make lung-sparing surgery more precise and successful for early-stage lung cancer patients.
What could go wrong
This is an early-phase trial with only 89 participants, so results may not apply broadly. The technique is new and may not improve outcomes or could have unforeseen risks.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.